Latest KFF Health News Stories
Watch: Anthony Fauci Defends Feds’ Covid Response, Calling Lawmakers’ Accusations ‘Preposterous’
At a June 3 congressional hearing that underscored the nation’s deep political divide over the coronavirus pandemic response, the longtime National Institutes of Health official addressed the agency’s controversies head-on.
After Grilling an NIH Scientist Over Covid Emails, Congress Turns to Anthony Fauci
In a trove of emails brought to light through a congressional probe, a former close adviser to longtime National Institutes of Health official Anthony Fauci spoke of hiding messages from public disclosure.
An NIH Genetics Study Targets a Long-Standing Challenge: Diversity
In his 2015 State of the Union address, President Barack Obama announced a precision medicine initiative that would later be known as the All of Us program. The research, now well underway at the National Institutes of Health, aims to analyze the DNA of at least 1 million people across the United States to build a diverse health database. The key word there is “diverse.” So […]
Robert F. Kennedy Jr. Is Wrong About a Ban on NIH Research About Mass Shootings
Since 2020, the National Institutes of Health and other federal agencies have collectively funded millions of dollars in gun-related research, including studies addressing mass shootings.
Genetics Studies Have a Diversity Problem That Researchers Struggle To Fix
Researchers in Charleston, South Carolina, are trying to build a DNA database of 100,000 people to better understand how genetics affects health risks. But they’re struggling to recruit enough Black participants.
The NIH Hopes To Make TMJ ‘Bearable.’ It Has a Long Way To Go.
The National Institutes of Health is spending more money than ever to solve the mysteries of TMJ disorders — little-understood ailments that afflict as many as 33 million Americans. Temporomandibular joint disorders, known as TMJ or TMD, cause pain in the jaw and face that can range from discomfort to disabling, with severe symptoms far […]
Republicans Once Championed Public Health. What Happened?
It wasn’t that long ago that Republicans were all-in on boosting public health spending. “The highest investment priority in Washington should be to double the federal budget for scientific research,” former House Speaker Newt Gingrich (R-Ga.) wrote in a 1999 op-ed in The Washington Post. Big spending increases for the National Institutes of Health soon […]
KFF Health News' 'What the Health?': A Very Good Night for Abortion Rights Backers
Abortion rights backers won major victories in at least five states in the 2023 off-year elections Nov. 7, proving the staying power of abortion as a political issue in the wake of the Supreme Court’s 2022 decision overturning Roe v. Wade. Meanwhile, the National Institutes of Health finally has a new director, after Democrats temporarily blocked President Joe Biden’s nominee over a mostly unrelated fight about prescription drug prices. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Julie Appleby, who reported and wrote the latest “Bill of the Month” feature.
KFF Health News' 'What the Health?': The New Speaker’s (Limited) Record on Health
The House finally has a new speaker: Mike Johnson (R-La). He’s a relative newcomer who’s been a lower-level member of the House GOP leadership. And while he’s an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia’s Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
Biden Pick to Lead NIH Finally Has Her Day, but Still Gets Caught Up in Drug Price Debate
Monica Bertagnolli, the president’s choice to head the National Institutes of Health, appeared before a Senate committee this week. Her confirmation has been held up by Sen. Bernie Sanders (I-Vt.), who has demanded President Joe Biden work more aggressively to lower prescription drug prices.
The NIH Ices a Research Project. Is It Self-Censorship?
The National Institutes of Health appeared to be digging into health misinformation. But then the federal agency stepped back. It can’t quite explain why, sometimes even offering contradictory explanations.
KFF Health News' 'What the Health?': Congress Is Out. The Presidential Campaign Is In.
Congress is in recess until after Labor Day, and lawmakers won’t have much time when they return to get the government funded before the next fiscal year. Meanwhile, the Republican campaign for president has begun in earnest, and while repealing the Affordable Care Act is no longer the top promise, some candidates have lively ideas about what to do with federal health programs. Alice Miranda Ollstein of Politico, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Phil Galewitz, who reported the latest KFF Health News-NPR “Bill of the Month,” about how a bill that should never have been sent created headaches for one patient.
KFF Health News' 'What the Health?': Let’s Talk About the Weather
It’s been the summer of broken weather records around the world — for heat, rain, and wildfire smoke — advertising the risks of climate change in a big way. But, apparently, it’s not enough to break the logjam in Washington over how to address the growing climate crisis. Meanwhile, in Texas, women who were unable to get care for pregnancy complications took their stories to court, and Congress gears up to — maybe — do something about prescription drug prices. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Rachel Cohrs of Stat join Julie Rovner, KFF Health News’ chief Washington correspondent, to discuss these issues and more. Also this week, Rovner interviews Meena Seshamani, the top administrator for the federal Medicare program.
Watch: Going Beyond the Script of ‘The G Word’ and How Government Responds to Disease (Or Not)
KHN Editor-in-Chief Elisabeth Rosenthal joins comedian Adam Conover to discuss his new Netflix series, “The G Word,” which examines the federal government’s role in Americans’ lives, and how it plays out in the covid era.
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
KHN’s ‘What the Health?’: Funding for the Next Pandemic
In his proposed budget, President Joe Biden called for a boost in health spending that includes billions of dollars to prepare for a future pandemic. But that doesn’t include money he says is needed immediately for testing and treating covid-19. Also this week, federal regulators authorized a second booster shot for people 50 and older yet gave little guidance to consumers about who needs the shot and when. Amy Goldstein of The Washington Post, Jennifer Haberkorn of the Los Angeles Times, and Rachana Pradhan of KHN join KHN’s Mary Agnes Carey to discuss these issues and more. Plus, Julie Rovner interviews KHN’s Julie Appleby, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a very expensive air ambulance ride.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Fueron excluidas de los ensayos clínicos, una decisión que expertos cuestionan. Las dudas sobre si recomendar la vacuna contra COVID a las embarazadas al parecer ha generado más enfermedad y muerte.
Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses
Clinical trials of covid-19 vaccines excluded pregnant people, which left many women wondering whether to get vaccinated.
Wartime Trauma Hits Close to Home for Scholar of Dementia
The federal government is putting up $7.2 million for a study into the correlation between war trauma and dementia in Vietnamese immigrants. Oahn Meyer, an associate professor at the University of California-Davis who is leading the study, wonders whether her mother’s dementia is linked to trauma she suffered during the Vietnam War.
